About the IMSS
What is the IMSS?
The Irish Mass Spectrometry Society, IMSS , is a voluntary society with the aim of providing a forum for practitioners of Mass Spectrometry in Ireland. The Society is run by a committee elected every two years and aims to hold one full-day scientific meeting in May each year.
The first meeting of Irish mass spectrometry users was in 1987 when a very successful meeting was held in on May 28th in UCD Belfield. In September 1993, an MS users group was set up. An inaugural meeting was held in May 1994, a Society was formed and a committee put in place. The name "The Irish Mass Spectrometry Society" was adopted at the 1996 AGM.
The Society was re-activated in 2007 following a few years of dormancy after the AGM of 2003. The Society is an Institutional Affiliate of the International Mass Spectrometry Foundation, organisers of the biennial IMSC meeting.
The Conference
TICKETS - SOLD OUT
One Day of Mass Spectrometry Talks
16.May.2019
09:30 am*
* breakfast and registration from 8:30am
The Irish Mass Spectrometry Society (IMSS) is a voluntary society with the aim of providing a forum for practitioners of Mass Spectrometry in Ireland. The Society is run by a committee elected every two years and aims to hold one full-day scientific meeting in May each year. This years conference will take place in NIBRT on the UCD campus. We look forward to seeing you there!
IMPORTANT DATES:
-
Registration deadline, Monday April 22th, 2019
-
Student/Post-doc poster submissions, Monday, April 15th, 2019
-
Student presentations competition, Monday, April 15th, 2019
Agenda - 2019
08.30 - 09.30: Registration & Breakfast.
09.30 - 09.35: Open meeting
09.35 - 10.35: Keynote speaker – Dr. Michael Boyne – ‘The Utility of Mass Spectrometry in Drug Development’
10.35 – 10.40: Group Photo
10.40 – 11.00: Break
11.00 - 11.30: Dr. Olivier Chevallier (QUB, Institute for Global Food Security) – ‘New integrated approaches to tackle global rice fraud’
11.30 – 11.45: 1st Student Competition Talk
11.45 – 12.10: Dr. Paula Meleady (DCU) – ‘Applications of Proteomics and Phosphoproteomics to Improve the Growth and Productivity of Recombinant Chinese Hamster Ovary Cells’
12.10 – 12.35: Dr. John Keegan, Public Analysts Laboratory, Dublin – ‘Analysis of Pyrrolizidine Alkaloids and Tropane Alkaloids in Foodstuffs by UPLC-MS/MS’
12.35 – 12.50: 2nd Student Competition Talk
12.50 – 13.45: Lunch
13.45 – 14.10: Dr. Robert Graham SFHEA (QUB) – ‘Biomarkers in Ovarian Cancer’
14.10 – 14.25: Dr. Sara Carillo, NIBRT – ‘Using Native MS to Assist Biopharmaceutical Development and Manufacturing’
14.25 – 14.40: Dr. Noemi Dorival-Garcia, NIBRT – ‘High-Throughput, Multi-Attribute Continuous Product Characterisation Platform for Increased Process Control Monitoring’
14.40 – 15.00: Dr. Susan Joyce, UCC – ‘Bile acids – New Twists on a Very Old Molecule’
15.00 – 15.15: 3rd Student Competition Talk
15.15 – 15.40: Dr. Sanja Trajkovic – ‘Nuritas: from Food Molecular Data to Creating New Treatments Utilizing Mass Spectrometry’
15.40 – 15.55: Dr. Sandra Murphy – IMSS Student Presentation Bursary winner 2018
15.55 – 16.00: Bursary winners/certificate presentations
16.00 – 16.05: Closing meeting
16.05 – 17.30: Drinks/LinkedIn Networking in Radisson Blu St. Helen’s Hotel, Dublin
Speakers - 2019
KEYNOTE SPEAKER
Dr. Michael Boyne
Michael Boyne is the VP of Product Development and Analytics at Cour Pharmaceuticals. In this role, he oversees the overall pipeline and all aspects of CMC and R&D. Before joining Cour, he was a Senior Consultant at BioTechLogic where he advised pharmaceutical manufacturers on drug development and CMC strategy, including drafting, reviewing, and authoring Pharmaceutical Quality/CMC sections of the CTD for regulatory submissions. Prior to consulting, he was a Research Chemist in the Division of Pharmaceutical Analysis at the US Food and Drug Administration where he established a laboratory developing and applying modern analytical technologies for the evaluation and regulation of complex drug products. Michael has authored over 40 peer-reviewed publications and is an internationally recognized speaker on the application of modern analytical technologies to drug development. He is the past chair of the 15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry and sits on the organizing committee for the CASSS meeting on Cell and Gene Therapies. Michael was a postdoctoral scholar at Washington University Medical School in Saint Louis where he was an American Cancer Society/Canary Foundation Fellow in Early Detection. Michael has a BA in Chemistry from Northwestern University, Evanston, IL and a PhD in Chemistry from the University of Illinois Urbana-Champaign.
Dr. John Keegan
Public Analysts Laboratory
Dublin
The Public Analyst Laboratory (PAL) is a modern food safety facility which plays its full part in ensuring that, with the Food Safety Authority of Ireland, the Environmental Health Service and other agencies, the food available for the Irish consumer is safe and wholesome. We are an Official Food Control laboratory within the Health Service Executive (HSE).
Dr. Noemi Dorival-Garcia
Research Fellow
NIBRT - Dublin
PhD in Analytical Chemistry, with wide experience in mass-spectrometric based methods (LC, GC, ICP) for the development and validation of analytical methods in complex environmental/biological matrices, for the determination of emerging contaminants to allow monitoring and regulation of these contaminants in wastewater treatment, composting plants, drinking water and regulatory agencies.
Dr. Olivier Chevallier
Manager of Mass Spectrometry Core Unit
Queen's University Belfast
My talk will be on new integrated approaches to tackle global rice fraud.
Dr. Paula Meleady
Associate Director
National Institute for Cellular Biotechnology
I am interested in the proteomic and phosphoproteomic analysis of recombinant mammalian cells in order to gain insights to improving productivity of biopharmaceuticals. This involves genetically engineering CHO cells to produce recombinant protein products (e.g. monoclonal antibodies) more efficiently. I also perform research into the proteomic analysis of membrane proteins from cancers to identify cell surface targets that may be amenable to therapeutic intervention, e.g. with monoclonal antibody and/or antibody drug conjugate (ADC) therapies.
Dr. Sanja Trajkovic
Head of Proteomics & Analytical Science
Nuritas Ltd.
Our mission is clear, we want to use our unique capabilities to tackle the health challenges facing the world of today as well as the world of tomorrow and, ultimately, improve the lives of billions of people around the globe.
Dr. Sara Carillo
Applications Development Team Leader
NIBRT
Dr. Sara Carillo is the applications development team leader in the Characterization and Comparability Laboratory in NIBRT, Ireland. Sara completed her PhD in Chemical Science at the University of Naples in 2013 working on bacterial glyco-conjugates structural characterization. In 2015, Sara joined Dr. Jonathan Bones’s research group in NIBRT, working on CHO cell glycome and biotherapeutics characterization.
Bursary Winner 2018
Dr. Sandra Murphy
Post-doctoral Research Associate
Newcastle University
"I was awarded the IMSS bursary of €1,000 as a final year PhD student in May 2018. This bursary enabled me to attend the Proteomics in Cell Biology and Disease Mechanisms conference at EMBL, Heidelberg. As a proteomics research associate in the UK, attending this conference allowed me to further develop my professional network."
